BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21460252)

  • 21. NUAK family kinase 2 is a novel therapeutic target for prostate cancer.
    Fu W; Zhao MT; Driver LM; Schirmer AU; Yin Q; You S; Freedland SJ; DiGiovanni J; Drewry DH; Macias E
    Mol Carcinog; 2022 Mar; 61(3):334-345. PubMed ID: 34818445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Declination of long noncoding RNA paternally expressed gene 10 inhibits A375 cells proliferation, migration, and invasion via mediating microRNA-33a.
    Fu Y; Bi Y; Wang F; Chen X; Liu H
    J Cell Biochem; 2019 Dec; 120(12):19868-19877. PubMed ID: 31318088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hmgb1 inhibits Klotho expression and malignant phenotype in melanoma cells by activating NF-κB.
    Xie B; Cao K; Li J; Chen J; Tang J; Chen X; Xia K; Zhou X; Cheng Y; Zhou J; Xie H
    Oncotarget; 2016 Dec; 7(49):80765-80782. PubMed ID: 27779100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4.
    Wei CY; Wang L; Zhu MX; Deng XY; Wang DH; Zhang SM; Ying JH; Yuan X; Wang Q; Xuan TF; He AQ; Qi FZ; Gu JY
    J Exp Clin Cancer Res; 2019 Mar; 38(1):137. PubMed ID: 30922374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
    Guo H; Cheng Y; Martinka M; McElwee K
    Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
    Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
    BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An integrative pan-cancer investigation reveals common genetic and transcriptional alterations of AMPK pathway genes as important predictors of clinical outcomes across major cancer types.
    Chang WH; Lai AG
    BMC Cancer; 2020 Aug; 20(1):773. PubMed ID: 32807122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
    Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
    Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High G2 and S-phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosis.
    Xu T; Ma M; Chi Z; Si L; Sheng X; Cui C; Dai J; Yu S; Yan J; Yu H; Wu X; Tang H; Yu J; Kong Y; Guo J
    Cancer Sci; 2018 Jun; 109(6):1787-1798. PubMed ID: 29660787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomewide RNAi screen identifies protein kinase Cb and new members of mitogen-activated protein kinase pathway as regulators of melanoma cell growth and metastasis.
    Schönherr M; Bhattacharya A; Kottek T; Szymczak S; Köberle M; Wickenhauser C; Siebolts U; Saalbach A; Koczan D; Magin TM; Simon JC; Kunz M
    Pigment Cell Melanoma Res; 2014 May; 27(3):418-30. PubMed ID: 24406113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.
    Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G
    Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy.
    Pópulo H; Caldas R; Lopes JM; Pardal J; Máximo V; Soares P
    Expert Opin Ther Targets; 2015 Jun; 19(6):733-45. PubMed ID: 25976231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a functional polymorphism within the 3'-untranslated region of denticleless E3 ubiquitin protein ligase homolog associated with survival in acral melanoma.
    Yang L; Dai J; Ma M; Mao L; Si L; Cui C; Sheng X; Chi Z; Yu S; Xu T; Yu J; Kong Y; Guo J
    Eur J Cancer; 2019 Sep; 118():70-81. PubMed ID: 31325875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metastatic Melanoma Progression Is Associated with Endothelial Nitric Oxide Synthase Uncoupling Induced by Loss of eNOS:BH4 Stoichiometry.
    Melo FHM; Gonçalves DA; Sousa RX; Icimoto MY; Fernandes DC; Laurindo FRM; Jasiulionis MG
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.
    Wang W; Chen H; Liu Z; Qu P; Lan J; Chen H; Zou L; Qiu J
    Br J Cancer; 2016 Feb; 114(3):305-13. PubMed ID: 26742010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PI3K/AKT/mTOR pathway inhibitors inhibit the growth of melanoma cells with mTOR H2189Y mutations in vitro.
    Wu X; Yu J; Yan J; Dai J; Si L; Chi Z; Sheng X; Cui C; Ma M; Tang H; Xu T; Yu H; Kong Y; Guo J
    Cancer Biol Ther; 2018 Jul; 19(7):584-589. PubMed ID: 29708815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression analysis after receptor tyrosine kinase activation reveals new potential melanoma proteins.
    Teutschbein J; Haydn JM; Samans B; Krause M; Eilers M; Schartl M; Meierjohann S
    BMC Cancer; 2010 Jul; 10():386. PubMed ID: 20663135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An analysis of p16 tumour suppressor gene expression in acral lentiginous melanoma.
    Chana JS; Grover R; Wilson GD; Hudson DA; Forders M; Sanders R; Grobbelaar AO
    Br J Plast Surg; 2000 Jan; 53(1):46-50. PubMed ID: 10657449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a novel substrate for TNFalpha-induced kinase NUAK2.
    Yamamoto H; Takashima S; Shintani Y; Yamazaki S; Seguchi O; Nakano A; Higo S; Kato H; Liao Y; Asano Y; Minamino T; Matsumura Y; Takeda H; Kitakaze M
    Biochem Biophys Res Commun; 2008 Jan; 365(3):541-7. PubMed ID: 18023418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.